Kalaris Therapeutics (KLRS) Cash from Financing Activities (2020 - 2026)
Kalaris Therapeutics (KLRS) reported Cash from Financing Activities of -$377,000 for Q2 2026.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Kalaris Therapeutics' Cash from Financing Activities came in at $45.67 million, down 60.2% year-over-year; for FY2025, it came in at $155.01 million, up 709.9% from FY2024.
- Cash from Financing Activities has a five-year compound annual growth rate of -11.9% (FY2020 to FY2025).
- By year, Cash from Financing Activities came in at $19.14 million in FY2024 (-72.8%), $70.5 million in FY2023 (-44.5%), $126.96 million in FY2022 and $232,000 in FY2021 (-99.9%).
- Five-year quarterly Cash from Financing Activities spans a low of -$1.7 million in Q1 2026 and a high of $126.43 million in Q3 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Kalaris Therapeutics | 68.80 Mn | 68.80 Mn | - | -377,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -377,000.00 |
| Mar 31, 2026 | -1.70 Mn |
| Dec 31, 2025 | 47.74 Mn |
| Mar 31, 2025 | 107.27 Mn |
| Dec 31, 2024 | 7.58 Mn |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 4.98 Mn |
| Mar 31, 2024 | 6.58 Mn |
| Dec 31, 2023 | 11,000.00 |
| Dec 31, 2022 | 292,000.00 |
| Sep 30, 2022 | 126.43 Mn |
| Dec 31, 2021 | 65,000.00 |
| Dec 31, 2020 | -354,000.00 |
API Access
Kalaris Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();